IGC Pharma, Inc.
For the period ended Dec 2, 2026. Filed Oct 22, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 2, 2026 · Filed Oct 22, 2026
Contents
Aligned With Our Stockholders
In June 2026, Claudia Grimaldi, our Principal Financial Officer, and I agreed to accept shares of common stock, rather than cash, for about $1.15 million the Company owed us, including funds we had advanced to the Company. We made that choice because we believe in what we are building, and because we want our own rewards tied to the same measure as yours: the value of IGC’s shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.